# The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life

> **NCT05991128** · PHASE4 · UNKNOWN · sponsor: **China-Japan Friendship Hospital** · enrollment: 170 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction
- Iron Deficiencies
- Acute Heart Failure

## Interventions

- **DRUG:** Ferric derisomaltose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05991128
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05991128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05991128, "The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05991128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*